Beneficial effects of nafazatrom on ischemic reperfused myocardium
- 1 June 1984
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 102 (1) , 63-70
- https://doi.org/10.1016/0014-2999(84)90338-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The beneficial effects of nafazatrom (BAYg6575) on experimental coronary thrombosisAmerican Heart Journal, 1984
- The effects of oral nafazatrom (=BAYg 6575) on canine coronary artery thrombosis and myocardial ischemiaBasic Research in Cardiology, 1983
- Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog.Circulation, 1983
- The effect of ibuprofen on accumulation of indium-111-labeled platelets and leukocytes in experimental myocardial infarction.Circulation, 1982
- Nafazatrom (bay g 6575) inhibition of tumor cell lipoxygenase activity and cellular proliferationFEBS Letters, 1982
- Determinants of arrhythmic death due to coronary spasm: effect of preexisting coronary artery stenosis on the incidence of reperfusion arrhythmia.Circulation, 1982
- Technique for precise, graded arterial stenosis and occlusionBasic Research in Cardiology, 1977
- The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs.Circulation, 1977
- Effects of acetylsalicylic acid, dipyridamole, and hydrocortisone on epinephrine-induced myocardial injury in dogsAmerican Heart Journal, 1976
- Protection against epinephrine-induced myocardial necrosis by drugs that inhibit platelet aggregationThe American Journal of Cardiology, 1972